Contact

Daria Pašalić
Editor-in-Chief
Department of Medical Chemistry, Biochemistry and Clinical Chemistry
Zagreb University School of Medicine
Šalata ul 2.
10 000 Zagreb, Croatia
Phone +385 (1) 4590 205; +385 (1) 4566 940
E-mail: dariapasalic [at] gmail [dot] com

Useful links

Original scientific article

Hossein Hadinedoushan1, Abbas Aflatounian2, Morteza Anvari3. The Role of IL-2 and rheumatoid factor in recurrent spontaneous abortion. Biochemia Medica 2008;18(2):201-5. http://dx.doi.org/10.11613/BM.2008.020

1 Immunology Department, Research and Clinical Centre for Infertility, Yazd, Iran

2 Gynecology and Obstetrics Department, Research and Clinical Centre for Infertility, Yazd, Iran

3 Anatomy Department, Research and Clinical Centre for Infertility, Yazd, Iran

 

*Corresponding author: hhadin [at] ssu [dot] ac [dot] ir

 

Abstract

Objective: Recurrent spontaneous abortion (RSA), the repetition of three or more consecutive abortions, occurs in approximately 1–2% of reproductive-aged women. It has been postulated that a number of repeated pregnancy losses may be related to immune causes. The purpose of this study was to determine the role of Interleukin (IL)-2 and Rheumatoid Factor (RF) in RSA.

Materials and methods: This case control study was carried out on two different groups. Group I consisted of fifty-six women with a history of three or more RSA and group II consisted of sixty-three healthy women who have had no abortion history, with at least one successful pregnancy. The sera were examined for the presence of IL-2 by ELISA method, and RF by latex agglutination test.

Results: Two out of 56 women in group I had IL-2 in serum. None of the women in group II had IL-2 in serum. Also, 53.5% of women in group I and 6% of women in group II were positive for RF in different titers. There were significant differences between groups I and II for RF (P = 0.002).

Conclusions: Serum IL-2 concentration does not affect pregnancy outcome, and the prevalence of RF in RSA women was higher than in normal controls. It is therefore recommended that the role of RF in pregnancy outcome should be investigated.

Key words: IL-2, rheumatoid factor, recurrent spontaneous abortion

Received: November 27, 2008                                                                                                                      Accepted: March 27, 2008

 

 

Introduction

Recurrent spontaneous abortions (RSA) are still a frequent reproductive problem worldwide, with three or more affecting 1-2% of women of reproductive age (1). Despite several well established etiologic factors, the cause of RSA cannot be determined in almost 50% of cases. It has been postulated that a number of these repeated pregnancy losses may be related to immune causes (2). The response of T helper (Th) cells following activation is characterized functionally according to the cytokines they produce. Th1 cells secrete mainly interleukin (IL)-2, interferon (IFN)-γ and tumor necrosis factor (TNF)-β (3). IL-2 figures prominently among cytokines that are particularly related to the survival of the conceptus. Chaouat et al. (1990) showed that administration of IL-2 to pregnant mice causes abortion (4).

Rheumatoid factors (RF) are antibodies that recognize the Fc portion of IgG molecules as their own antigens. RFs can be of any immunoglobulin isotype (IgM, IgG, IgE). Most of the RFs measured clinically are of IgM class (5). Among healthy population, the frequency of RF positive individuals ranges from 1.3-4% in Caucasians to 30% in some tribes of North American Indians (6). A small subset of B cells that express CD5, known as B-1a cells, appear to produce RF (7). Many studies have illustrated the essential role of T cells in class switching where cytokine production has an important impact on the type of immunoglobulin produced by B cells (8).

The aim of this study was to compare the levels of IL-2 (Th1 cytokine) and RF in the sera of women having history of RSA with those of the control group.

 

Materials and methods

Patients

This case control study was carried out on two different groups referred to Yazd Research and Clinical Centre for Infertility. Group I consisted of 56 women with a history of three or more RSA and group II consisted of 63 healthy women who had no abortion history, with at least one successful pregnancy. Abortion samples were normal in karyotype, TORCH negative and had no anatomical or endocrine problems, absence of anti-phospholipid antibodies of both IgM and IgG classes, anti-cardiolipin antibodies of IgM, IgG and IgA classes, and antinuclear antibodies of IgM and IgG classes. All cases were primary RSA. Demographic information such as age, number of abortions, gestational age at the last abortion for RSA women, and the number of pregnancies in control group were provided. The local Institutional Review Board approved experimental procedures, and signed informed consent was obtained from each participant.

 

Methods

Blood samples (5 mL were collected and sera were examined for the presence of IL-2 according to manufacturer’s instructions (Bender Medsystem GmbH, Vienna, Austria). The procedure is explained briefly as follows: 1) 100 µL of each sample in duplicate was added to the well; also, the same amount of sample diluents was placed into blank wells; 2) 50 µL of diluted Biotin-Conjugate was added to all wells and was incubated at room temperature for 2 hours; 3) microwell strips were washed 4 times and 100 µL diluted Streptavidin-HRP were added to all wells; 4) samples were first incubated at room temperature for 1 hour and then washed 4 times; 5) finally TMB substrate solution was added to all wells and was incubated at room temperature for 15 minutes; 6) the enzyme reaction was stopped by pipetting 100 µL of stop solution into the wells and absorbance of each microwell was read at 450 nm and 620 nm as the reference wave length.

The sensitivity of IL-2 assay was 3.5 pg/mL. The overall intra-assay and inter-assay coefficient of variation was calculated to be 5.2% and 8%, respectively. The presence of RF (anti-human immunoglobulin) was determined by a latex agglutination test (Bionic, Iran) according to manufacturer’s instructions and the presence of agglutination was considered positive. Positive samples were tested in different dilutions to 1/64 titers.

 

Statistical analysis

Statistical analysis was performed using statistical software V 12.0 (SPSS Inc, Chicago, IL). Chi-square test was used for comparison of the incidence of RF between groups.

 

Results

The mean age of women in group I was 28 ± 4 years (range 21-42) and for those in group II it was 27 ± 5 years (range 18-37). There was no significant difference in the age of women in two groups. Pregnancy loss numbers varied from 3 to 10 (4 ± 1). Mean gestational age in the last abortion was 11.45 ± 2.85 weeks in group I. Two out of 56 women in group I had IL-2 in serum (35 pg/mL and 10 pg/mL). None of the women in group II had IL-2 in serum. Also, 53.5% of women in group I and 6% of women in group II were positive for RF in different titers (Figure 1). There were statistically significant differences between groups I and II for RF (P = 0.002).

 

 

Figure 1. The frequency of RF titers in RSA (case) and control groups.

 

Discussion

In recent years, some progress has been made in better understanding of recurrent abortion and in the offer of diagnostic tools and management. RSA is still the most common complication during pregnancy (9). Production of cytokines and distribution of immune cells during pregnancy may provide important information for predicting pregnancy outcome, e.g. the term or loss of pregnancy (10). In this study, we measured IL-2 cytokine in sera of women with history of RSA and in reproductive age-matched women without any abortion. Although we were unable to detect IL-2 in the sera of our control group, elevated concentrations of IL-2 in normal pregnancy as compared with non-pregnant controls have been reported (11). This difference in results may be related to the age of patients, detection kits, race and socio-economical status. Only two out of fifty-six women with the history of RSA were positive for IL-2 in serum. There are some studies which indicate that peripheral blood lymphocytes of women with RSA secrete increased concentrations of certain Th1 cytokines, such as IL-2 upon stimulation by mitogens or antigens when compared in women with successful pregnancy (12, 13). However, Th1 cytokine production is down-regulated during pregnancy (14). Our results failed to show similar profile of IL-2 production in the studied sera. As part of this research, also RF was measured in two groups. Our results showed that 53.5% of women with the history of RSA were positive for RF, and its level was significantly higher than in controls. It has been reported that some autoantibodies adversely affect the course of pregnancy and fetal growth (15). For RF, the only report referring to its increase during pregnancy is that of Ailus et al (16). 8.3% of women with RSA history that were studied by Iijima et al. had RF in their sera (17). RFs are autoantibodies associated with rheumatoid arthritis. They can be detected in normal individuals, although transiently. Recently, it has been shown that B cells which produce RF only do so when activated by two signals, one from engagement of the B cell receptor and the other from recognition of a pathogen-associated molecular pattern through a Toll-like receptor. These autoantibodies thus link the innate and acquired immune response (18). The roles of some infectious agents in recurrent abortions are well known. However, there might be some correlation between microbial abortion and RF production.

 

Conclusion

The results of this study showed that serum IL-2 concentration did not affect pregnancy outcome. However, the prevalence of RF was higher among patients with RSA than in normal women with no history of abortion. Therefore, it is recommended that the role of RF in pregnancy outcome should be investigated.

 

Acknowledgements

The financial support was provided by Shahid Sadoughi University of Medical Sciences. The authors are grateful to Mr Hossein Fazli for his technical assistance.

 

References

1.     Regan L. Overview of recurrent miscarriage. Gynaecology Forum 1998;3:3-7.

2.     Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003;9(2):163-74.

3.     Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;3:138-46.

4.     Chaouat G, Menu M, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBAč×čDBA/2 mice by lymphokine therapy. J Reprod Fertil 1990;9(2):447-57.

5.     Nielen MMJ, Van Schaardenburg D, Reesink HW, Van de Stadt RJ, Van der Hors-Bruinsma IE, De Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis. Arthritis Rheum 2004;50:380-6.

6.     Jansen AL, van der Horst-Bruinsma I, van Schaardenburg D, van de Stadt RJ, de Koning MH, Dijkmans BA. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002;29(10):2034-40.

7.     Mantovani L, Wilder RL, Casali P. Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors. J Immunol 1993;151(1):473-88.

8.     Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol 1996;8:199-205.

9.     Clifford K, Rai R, Watson H, Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994;9:1328-32.

10.   Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the materno-fetal relatioship: successful allopregnancy is a Th2 phenomenon. Immunol Today 1993;14:353-355.

11.   Favier R, Edelman P, Mary JY, Sadoul G, Douay L. Presence of elevated serum interleukin-2 levels in pregnant women. N Engl J Med 1990;322(4):270.

12.   Hossein H, Mahroo M, Abbas A, Firouzeh A, Nadia H. Cytokine production by peripheral blood mononuclear cells in recurrent miscarriage. Cytokine 2004;28(2):83-6.

13.   Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod 2000:15(3):713-8.

14.   Rezaei A, Dabbagh A. T-helper (1) cytokines increase during early pregnancy in women with a history of recurrent spontaneous abortion. Med Sci Monit 2002:8(8):607-10.

15.   Kotlan B, Padanyi A, Batorfi J, Fulop V, Szigetvari I, Rajczy K, et al. Alloimmune and autoimmune background in recurrent pregnancy loss - successful immunotherapy by intravenous immunoglobulin. Am J Reprod Immunol 2006;55(5):331-40.

16.   Ailus KT. A follow-up study of immunoglobulin levels and autoantibodies in an unselected pregnant population. Am J Reprod Immunol 1994;31(4):189-96.

17.   Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997;90(3):364-9.

18.   Chaiamnuay S, Bridges SL Jr. The role of B cells and autoantibodies in rheumatoid arthritis: Pathophysiology 2005;12(3):203-16.